Skip to main content

Advertisement

SpringerLink
Log in

Latest advances in intracerebral hemorrhage

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Despite the fact that intracerebral hemorrhage (ICH) is the deadliest and least treatable of all stroke subtypes, historically researchers have directed most of their efforts toward ischemic strokes. However in the past few years this tendency has been changing, and several studies are showing very interesting results that allow us to believe that in the following years ICH management will change dramatically, paralleling the recent revolution that ischemic stroke treatment experienced in the past decade. Studies offering a better understanding of risk factors, pathophysiology, and treatment will help in primary and secondary prevention and also in developing therapeutic strategies to reduce brain damage. This review comments on some of the most relevant publications during the past year in any field related to ICH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Priorities for clinical research in intracerebral hemorrhage: report from a national institute of neurological disorders and stroke workshop. Stroke 2005, 36:e23–e41.

  2. Feldmann E, Broderick JP, Kernan WN, et al.: Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005, 36:1881–1885.

    Article  PubMed  Google Scholar 

  3. Kim HC, Kang DR, Nam CM, et al.: Elevated serum aminotransferase level as a predictor of intracerebral hemorrhage: Korea medical insurance corporation study. Stroke 2005, 36:1642–1647.

    Article  PubMed  CAS  Google Scholar 

  4. Van Guelpen B, Hultdin J, Johansson I, et al.: Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke 2005, 36:1426–1431.

    Article  PubMed  CAS  Google Scholar 

  5. Woo D, Kaushal R, Chakraborty R, et al.: Association of apolipoprotein e4 and haplotypes of the apolipoprotein e gene with lobar intracerebral hemorrhage. Stroke 2005, 36:1874–1879.

    Article  PubMed  CAS  Google Scholar 

  6. Passero SG, Calchetti B, Bartalini S: Intracranial bleeding in patients with vertebrobasilar dolichoectasia. Stroke 2005, 36:1421–1425.

    Article  PubMed  Google Scholar 

  7. Brott T, Broderick J, Kothari R, et al.: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1–5.

    PubMed  CAS  Google Scholar 

  8. Fuji Y, Takeuchi S, Sasaki O, et al.: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998, 29:1160–1166.

    Google Scholar 

  9. Fujitsu K, Muramoto M, Ikeda Y, et al.: Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 1990, 73:518–525.

    PubMed  CAS  Google Scholar 

  10. Kazui S, Naritomi H, Yamamoto H, et al.: Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996, 27:1783–1787.

    PubMed  CAS  Google Scholar 

  11. Silva Y, Leira R, Tejada J, et al.: Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005, 36:86–91.

    Article  PubMed  Google Scholar 

  12. Orakcioglu B, Fiebach JB, Steiner T, et al.: Evolution of early perihemorrhagic changes—ischemia vs. Edema: an MRI study in rats. Exp Neurol 2005, 193:369–376.

    Article  PubMed  CAS  Google Scholar 

  13. Huang FP, Xi G, Keep RF, et al.: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 2002, 96:287–293.

    PubMed  Google Scholar 

  14. Chiueh CC: Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 2001, 25:138–147.

    Article  PubMed  CAS  Google Scholar 

  15. Shao J, Xi G, Hua Y, et al.: Intracerebral hemorrhage in the iron-deficient rat. Stroke 2005, 36:660–664.

    Article  PubMed  Google Scholar 

  16. Nakamura T, Xi G, Park JW, et al.: Holo-transferrin and thrombin can interact to cause brain damage. Stroke 2005, 36:348–352.

    Article  PubMed  CAS  Google Scholar 

  17. Nagatsuna T, Nomura S, Suehiro E, et al.: Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment. Cerebrovasc Dis 2005, 19:192–200.

    Article  PubMed  CAS  Google Scholar 

  18. Abilleira S, Montaner J, Molina CA, et al.: Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003, 99:65–70.

    Article  PubMed  CAS  Google Scholar 

  19. Alvarez-Sabin J, Delgado P, Abilleira S, et al.: Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: Relationship to clinical and radiological outcome. Stroke 2004, 35:1316–1322. MMPs constitute a fascinating field in ischemic and hemorrhagic stroke, and therapeutic approaches involving MMPs will certainly be developed in the following years.

    Article  PubMed  CAS  Google Scholar 

  20. Lee JM, Yin K, Hsin I, et al.: Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage. J Neurol Sci 2005, 230:249–254.

    Article  CAS  Google Scholar 

  21. Wang J, Tsirka SE: Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 2005, 128:1622–1633.

    Article  PubMed  Google Scholar 

  22. Ritter MA, Droste DW, Hegedus K, et al.: Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology 2005, 64:1233–1237.

    PubMed  CAS  Google Scholar 

  23. Lu A, Tang Y, Ran R, et al.: Brain genomics of intracerebral hemorrhage. J Cereb Blood Flow Metab 2005, In press. This is a novel study that in a very elegant way will help identify new therapeutic approaches for ICH.

  24. Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387–397. This is the first adequately powered randomized trial of open craniotomy and elective clot evacuation versus nonsurgical management. It confirmed the lack of clinical benefit of the routine surgical approach.

    PubMed  Google Scholar 

  25. Nakano T, Ohkuma H: Surgery versus conservative treatment for intracerebral haemorrhage—is there an end to the long controversy? Lancet 2005, 365:361–362.

    PubMed  Google Scholar 

  26. Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor vii for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785. This was first controlled study to show the benefit of any therapy for ICH. It was a confirmatory study that found the best dosage and has already started exciting developments for the entire stroke field

    Article  PubMed  CAS  Google Scholar 

  27. Qureshi AI, Mohammad YM, Yahia AM, et al.: A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005, 20:34–42.

    Article  PubMed  Google Scholar 

  28. Misra UK, Kalita J, Ranjan P, Mandal SK: Mannitol in intracerebral hemorrhage: A randomized controlled study. J Neurol Sci 2005, 234:41–45.

    Article  PubMed  CAS  Google Scholar 

  29. Belayev L, Saul I, Busto R, et al.: Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke 2005, 36:326–331.

    Article  PubMed  CAS  Google Scholar 

  30. Lee ST, Chu K, Jung KH, et al.: Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2005, In press.

  31. Wang J, Tsirka SE: Tuftsin fragment 1–3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 2005, 36:613–618.

    Article  PubMed  CAS  Google Scholar 

  32. Nan Z, Grande A, Sanberg CD, et al.: Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann N Y Acad Sci 2005, 1049:84–96.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vascular Neurology, University of Texas Houston Medical School, 6431 Fannin Street, 77030, Houston, TX, USA

    James C. Grotta MD

Authors
  1. Marc Ribo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James C. Grotta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James C. Grotta MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribo, M., Grotta, J.C. Latest advances in intracerebral hemorrhage. Curr Neurol Neurosci Rep 6, 17–22 (2006). https://doi.org/10.1007/s11910-996-0004-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-996-0004-0

Keywords

Search

Navigation